Rigel Pharmaceuticals, Inc. (RIGL) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $42.58 +4.39%
Financial Fact:
Total costs and expenses: 26.5M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Total costs and expenses: 26.5M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) reported Q2 EPS of ($0.35), in-line with the analyst estimate of ($0.35). Revenue for the quarter came in at $1.15 million versus the consensus estimate of $550 thousand.
For earnings history and earnings-related data on Rigel Pharmaceuticals, Inc. (RIGL) click here.
For earnings history and earnings-related data on Rigel Pharmaceuticals, Inc. (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Vivos Therapeutics posts 35% revenue gain but widens net loss
- Diana Shipping drops bid for Genco after price demands spike to $36.91
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
